Publisher： Karger
E-ISSN： 1421-9794|51|1|110-114
ISSN： 0009-3157
Source： Chemotherapy, Vol.51, Iss.1, 2005-04, pp. : 110-114
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Management of Inflammatory Bowel Disease: Does Rifaximin Offer Any Promise?
Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. :
Access to resources
Recommend
Management of Hepatic Encephalopathy: Role of Rifaximin
Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. :
Rifaximin in the Treatment of Infectious Diarrhea
Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. :
Management of Oesophageal Disease in the Elderly
The Australian Journal of Hospital Pharmacy, Vol. 31, Iss. 4, 2001-12 ,pp. :
Rifaximin, a Poorly Absorbed Antibiotic: Pharmacology and Clinical Potential
Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. :